Axa Parenterals, the leading sterile solution manufacturer in India, manufacture DELEXIGYL. It successfully reached its niche market in May 2017 with the effective marketing strategy of Delex Pharma.
DELEXIGYL Injection USP is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with Metronidazole Injection USP therapy.
It is currently available in selected Mercury Drug branches. DPII sells the product at a discounted price as it embodies its mission in bringing quality and cost-effective medicines to the every Filipino.
DISCLAIMER: The following contents are intended for healthcare professionals only. If you are a patient or general mass viewing this site, we advise you to clarify with your doctor any information you read herein.
|
Generic Name:
|
METRONIDAZOLE
|
|
Brand Name:
|
DELEXIGYL
|
|
Sizes:
|
500 mg/100 mL (0.05% w/v)
|
|
Preparation:
|
500 mg/100 mL (0.05% w/v); Solution for I.V. Infusion
|
|
Name of Manufacturer
|
Axa Parenterals Ltd
|
|
Place of Manufacturer:
|
India
|
|
Shelf Life
|
36 months
|
|
Storage Condition:
|
Store at temperature not exceeding 30 ͦC
|
|
Packaging:
|
LDPE plastic container (Box of 1’s)
|
|
FDA Registration:
|
DRP-6449-02
|
